Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer
- PMID: 18442812
- DOI: 10.1016/j.ejphar.2008.03.032
Combined antitumor activity of cucurbitacin B and docetaxel in laryngeal cancer
Abstract
Combination therapy with multiple drugs is a common practice in the treatment of cancer. The promising clinical activity of docetaxel has promoted considerable interest in combining it with other antitumor agents. To determine whether cucurbitacin B can enhance chemosensitivity to docetaxel in laryngeal cancer, in the present study, we investigated the combined antitumor effect of cucurbitacin B with docetaxel on Hep-2, a human laryngeal cancer cell line. We treated Hep-2 cells with cucurbitacin B alone or in combination with docetaxel and evaluated cell growth, cell cycle distribution, and apoptosis using MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide) assay, flow cytometry, and fluorescent microscopy. Our results showed that, in comparison with single agent treatment, the combination of cucurbitacin B and docetaxel produced greater efficacy in growth inhibition, cell cycle arrest at G2/M phase, and apoptosis induction. Measuring the modulation of regulators in the cell cycle, apoptosis and signal transductions by Western blot analysis showed that the combination effect of cucurbitacin B and docetaxel was due to suppress the expression of p-STAT3 (signal transducers and activators of transcription 3), Bcl-2, and cyclin B1. Moreover, our in vivo studies were reproduced in a mouse xenograft model, where, the combination of cucurbitacin B with docetaxel synergestively inhibited tumor growth. Together, this investigation suggests that cucurbitacin B combined with docetaxel may be a feasible strategy to enhance the effects of chemotherapy in patients with laryngeal cancer.
Similar articles
-
Cucurbitacin B, a small molecule inhibitor of the Stat3 signaling pathway, enhances the chemosensitivity of laryngeal squamous cell carcinoma cells to cisplatin.Eur J Pharmacol. 2010 Sep 1;641(1):15-22. doi: 10.1016/j.ejphar.2010.04.062. Epub 2010 May 17. Eur J Pharmacol. 2010. PMID: 20483353
-
Inhibitory effects of cucurbitacin B on laryngeal squamous cell carcinoma.Eur Arch Otorhinolaryngol. 2008 Oct;265(10):1225-32. doi: 10.1007/s00405-008-0625-9. Epub 2008 Feb 29. Eur Arch Otorhinolaryngol. 2008. PMID: 18309509
-
[Effects of cucurbitacin B on cell proliferation and apoptosis in Hep-2 cells].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008 May;22(9):403-7. Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008. PMID: 18652313 Chinese.
-
Preclinical experience with docetaxel in gastrointestinal cancers.Semin Oncol. 2005 Apr;32(2 Suppl 4):S3-9. doi: 10.1053/j.seminoncol.2005.04.002. Semin Oncol. 2005. PMID: 16015550 Review.
-
[Focus on cellular pharmacology of docetaxel].Bull Cancer. 2003 Dec;90(12):1067-70. Bull Cancer. 2003. PMID: 14715427 Review. French.
Cited by
-
Recent Advances in the Application of Cucurbitacins as Anticancer Agents.Metabolites. 2023 Oct 14;13(10):1081. doi: 10.3390/metabo13101081. Metabolites. 2023. PMID: 37887406 Free PMC article. Review.
-
Cucurbitacin B and cisplatin induce the cell death pathways in MB49 mouse bladder cancer model.Exp Biol Med (Maywood). 2020 May;245(9):805-814. doi: 10.1177/1535370220917367. Epub 2020 Apr 6. Exp Biol Med (Maywood). 2020. PMID: 32252554 Free PMC article.
-
Targeting STAT-3 signaling pathway in cancer for development of novel drugs: Advancements and challenges.Genet Mol Biol. 2020 Feb 10;43(1):e20180160. doi: 10.1590/1678-4685-GMB-2018-0160. eCollection 2020. Genet Mol Biol. 2020. PMID: 32167126 Free PMC article.
-
Growth inhibitory effect of Cucurbitacin E on breast cancer cells.Int J Clin Exp Pathol. 2013 Aug 15;6(9):1799-805. eCollection 2013. Int J Clin Exp Pathol. 2013. PMID: 24040444 Free PMC article.
-
Progress in Antimelanoma Research of Natural Triterpenoids and Their Derivatives: Mechanisms of Action, Bioavailability Enhancement and Structure Modifications.Molecules. 2023 Nov 24;28(23):7763. doi: 10.3390/molecules28237763. Molecules. 2023. PMID: 38067491 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
